Business
Gilead's Trodelvy Delayed Progression of a Common Type of Advanced Breast Cancer by 1.5 ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Gilead’s Trodelvy delayed progression of a common type of advanced breast cancer by 1.5 months in a study, a modest but statistically significant improvement ...'
Gilead’s Trodelvy delayed progression of a common type of advanced breast cancer by 1.5 months in a study, a modest but statistically significant improvement https://t.co/7on5Cvfz0S— Bloomberg (@business) June 4, 2022
(The above story first appeared on LatestLY on Jun 04, 2022 08:00 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
